276 related articles for article (PubMed ID: 31712271)
1. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
Zhang X; El-Serag HB; Thrift AP
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
[TBL] [Abstract][Full Text] [Related]
3. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
Pham C; Fong TL; Zhang J; Liu L
J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
[TBL] [Abstract][Full Text] [Related]
6. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
10. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
11. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
Petrick JL; Kelly SP; Altekruse SF; McGlynn KA; Rosenberg PS
J Clin Oncol; 2016 May; 34(15):1787-94. PubMed ID: 27044939
[TBL] [Abstract][Full Text] [Related]
12. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
13. Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.
Beal EW; Tumin D; Kabir A; Moris D; Zhang XF; Chakedis J; Washburn K; Black S; Schmidt CM; Pawlik TM
World J Surg; 2018 Mar; 42(3):835-840. PubMed ID: 28879603
[TBL] [Abstract][Full Text] [Related]
14. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.
Pocobelli G; Cook LS; Brant R; Lee SS
Liver Int; 2008 Nov; 28(9):1272-9. PubMed ID: 18384523
[TBL] [Abstract][Full Text] [Related]
16. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
[TBL] [Abstract][Full Text] [Related]
17. Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019.
Liu KS; Raza SA; El-Serag HB; Thrift AP
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551535
[TBL] [Abstract][Full Text] [Related]
18. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution.
Shea KA; Fleming LE; Wilkinson JD; Wohler-Torres B; McKinnon JA
Cancer; 2001 Mar; 91(5):1046-51. PubMed ID: 11251958
[TBL] [Abstract][Full Text] [Related]
20. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
